Evidence map›Paper›PMID 37053201›Full record

ArticlePloS one2023

The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.

David J Pascall, Elen Vink, Rachel Blacow, Naomi Bulteel, Alasdair Campbell, Robyn Campbell, Sarah Clifford, Chris Davis, Ana da Silva Filipe, Noha El Sakka and 27 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

David J PascallMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-7543-0860
Elen VinkMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.ORCID 0000-0001-8535-6214
Rachel BlacowMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Naomi BulteelNHS Fife, Kirkcaldy, Fife, United Kingdom.
Alasdair CampbellNHS Lothian, Edinburgh, United Kingdom.
Robyn CampbellNHS Lothian, Edinburgh, United Kingdom.
Sarah CliffordNHS Lothian, Edinburgh, United Kingdom.
Chris DavisMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Ana da Silva FilipeMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Noha El SakkaNHS Grampian, Aberdeen, United Kingdom.ORCID 0000-0003-0225-826X
Ludmila FjodorovaNHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Ruth ForrestNHS Fife, Kirkcaldy, Fife, United Kingdom.
Emily GoldsteinNHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Rory GunsonNHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
John HaughneyNHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Matthew T G HoldenPublic Health Scotland, Edinburgh, United Kingdom.
Patrick HonourNHS Borders, Melrose, Scottish Borders, United Kingdom.
Joseph HughesMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.ORCID 0000-0003-2556-2563
Edward JamesNHS Borders, Melrose, Scottish Borders, United Kingdom.
Tim LewisNHS Lothian, Edinburgh, United Kingdom.
Samantha LycettThe Roslin Institute, University of Edinburgh, Midlothian, United Kingdom.ORCID 0000-0003-3159-596X
Oscar MacLeanMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Martin McHughNHS Lothian, Edinburgh, United Kingdom.ORCID 0000-0002-0370-3700
Guy MollettMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Yusuke OnishiNHS Grampian, Aberdeen, United Kingdom.
Ben ParcellSchool of Life Sciences, University of Dundee, Dundee, United Kingdom.
Surajit RaySchool of Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0003-3965-8136
David L RobertsonMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Sharif ShabaanPublic Health Scotland, Edinburgh, United Kingdom.ORCID 0000-0001-8293-9481
James G ShepherdMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.ORCID 0000-0003-3915-048X
Katherine SmollettMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Kate TempletonNHS Lothian, Edinburgh, United Kingdom.
Elizabeth WastnedgeNHS Lothian, Edinburgh, United Kingdom.
Craig WilkieSchool of Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0003-0805-0195
Thomas WilliamsNHS Lothian, Edinburgh, United Kingdom.
Emma C ThomsonMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.ORCID 0000-0003-1482-0889
COVID-19 Genomics UK (COG-UK) Consortium

Funding

Medical Research Council MC_PC_19026Medical Research Council MC_PC_19027Medical Research Council MC UU 00002/11Medical Research Council MC_UU_00002/11Medical Research Council MC_UU_00034/6Medical Research Council MC UU 1201412Medical Research Council MC_UU_12014/12Medical Research Council MR/V038613/1Wellcome Trust
6 · The paper itself

Abstract

objectivesThe SARS-CoV-2 Alpha variant was associated with increased transmission relative to other variants present at the time of its emergence and several studies have shown an association between Alpha variant infection and increased hospitalisation and 28-day mortality. However, none have addressed the impact on maximum severity of illness in the general population classified by the level of respiratory support required, or death. We aimed to do this.

methodsIn this retrospective multi-centre clinical cohort sub-study of the COG-UK consortium, 1475 samples from Scottish hospitalised and community cases collected between 1st November 2020 and 30th January 2021 were sequenced. We matched sequence data to clinical outcomes as the Alpha variant became dominant in Scotland and modelled the association between Alpha variant infection and severe disease using a 4-point scale of maximum severity by 28 days: 1. no respiratory support, 2. supplemental oxygen, 3. ventilation and 4. death.

resultsOur cumulative generalised linear mixed model analyses found evidence (cumulative odds ratio: 1.40, 95% CI: 1.02, 1.93) of a positive association between increased clinical severity and lineage (Alpha variant versus pre-Alpha variants).

conclusionsThe Alpha variant was associated with more severe clinical disease in the Scottish population than co-circulating lineages.

Indexed as

COVID-19SARS-CoV-2GenomicsHumansRetrospective StudiesScotland

Identifiers

PMID37053201
PMCPMC10101505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.